Danielle Read
Physician Assistant · West Babylon, NYNPI 1174074660
Payments from drug & device makers
Across 71 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$391
- Lilly USA, LLC$201
- Pfizer$101
- AstraZeneca$95
- Exact Sciences$68
- Corcept Therapeutics$51
- plus $429 from 17 others
What the payments were for
- Food & beverage$1,336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $391 |
| Lilly USA, LLC | 10 | $201 |
| Pfizer | 6 | $101 |
| AstraZeneca | 6 | $95 |
| Exact Sciences | 3 | $68 |
| Corcept Therapeutics | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| GSK | 2 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Medicomp Inc | 1 | $33 |
| Lundbeck LLC | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Boston Scientific | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Resmed Corp | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| AbbVie | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $14 |
| Abbott | 1 | $12 |
| Clarus Therapeutics Inc. | 1 | $7 |
How this compares
$1,336 in reported general payments places this provider in the 80th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $85,211 |
| EliquisApixaban | 48 | $67,934 |
| JardianceEmpagliflozin | 43 | $63,916 |
| FarxigaDapagliflozin Propanediol | 25 | $38,741 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $25,236 |
| MounjaroTirzepatide | 17 | $21,479 |
| XareltoRivaroxaban | 19 | $21,013 |
| TrulicityDulaglutide | 11 | $20,209 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $9,824 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,838 |
| Novolog FlexpenInsulin Aspart | 19 | $2,284 |
| Levothyroxine Sodium | 143 | $2,205 |
| Atorvastatin Calcium | 255 | $2,043 |
| SynthroidLevothyroxine Sodium | 39 | $2,022 |
| Metoprolol Succinate | 140 | $1,918 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $391 | $85,21154 claims |
| PfizerEliquis | $101 | $67,93448 claims |
| Lilly USA, LLCMounjaro, Trulicity | $201 | $41,68828 claims |
| AstraZenecaFarxiga | $95 | $38,74125 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $43 | $35,06048 claims |
| Johnson & JohnsonXarelto | $20 | $21,01319 claims |
| AbbVieSynthroid | $19 | $2,02239 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in West Babylon
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.